Abstract:Objective:To study the clinical characteristics and prognosis of neonatal inborn error of metabolism (IEM) for better clinical diagnosis and treatment.Method:From January 2007 to June 2019, the clinical data and follow-up results of cases of IEM with neonatal onset admitted to neonatal ward of our hospital were analysed retrospectively.Result:A total of 838 children with IEM were treated during the period, including 88 cases of neonatal onset and/or diagnosed. 8 cases were excluded due to the combination of other serious nervous system diseases, and 80 cases were finally enrolled in the study. Methylmalonic aciduria (MMA) was the most common disorder (53/80, 66.2%). Among the 70 symptomatic patients, 48 cases (48/70, 68.6%) presented symptoms within 7 days after birth. The clinical manifestations of the children were not specific, and feeding difficulty was the most common (53/80, 66.2%) symptom, followed by neurological symptoms including encephalopathy (47/80, 58.8%) and convulsions (28/80, 35.0%). Laboratory tests showed that 85.0% (68/80) had hyperammonemia, 52.5% (42/80) had metabolic acidosis.The infants with moderate to severe metabolic acidosis were all diagnosed with organic acidemia. 56 cases completed EEG examinations within 24 hours after admission and 52 cases (92.9%) were abnormal. The mild-abnormal EEG showed immature sleep cycle or discontinuous background activity and the severe one showed low voltage or burst-suppression. The overall prognosis of these children was poor. 63 cases (78.8%) completed 18-month follow-up, 19 cases (30.2%) died and 29 cases (46.0%) had severe mental and motor retardation. The prognosis of children with moderate-and severe-abnormal background of EEG were significantly worse than children with normal or mild-abnormal background, and the differences were statistically significant ( P=0.012). Conclusion:IEM usually occurs within one week after birth, and the clinical manifestations are often unspecific. The diagnosis of metabolic diseases should be confirmed as soon as possible in infants with hyperammonemia and severe metabolic acidosis. Moderate-and severe-abnormal background activity of EEG may indicate a poor prognosis.

Inborn errors of metabolism and epilepsy in children

Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches

[Epilepsy and inborn errors of metabolism]

Metabolic epilepsies: approaches to a diagnostic challenge

Clinical manifestations and prognosis of neonate-onset inborn errors of metabolism

Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review

Clinical and biochemical footprints of inherited metabolic diseases. XV. Epilepsies

Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy

The Pathogenesis of Epilepsy Related to Primary Inherited Neurotransmitter Disorders and Advance in Its Diagnosis and Treatment

Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center

Disease spectrum, prevalence, genetic characteristics of inborn errors of metabolism in 21,840 hospitalized infants in Chongqing, China, 2017-2022

Neonatal seizures: the overlap between diagnosis of metabolic disorders and structural abnormalities. Case report

Developmental and epileptic encephalopathies

Etiological Spectrum and Clinical Characteristics of Neonates with High Risk of Inborn Errors of Metabolism: A Five-year Retrospective Analysis

Features of clinical and therapy in juvenile myoclonic epilepsy: an analysis of 87 cases

Genetic and epigenetic mechanisms of epilepsy: a review

[Inborn errors of metabolism. Advances in diagnosis and therapeutic]

New treatment paradigms in neonatal metabolic epilepsies

[Neonatal epileptics syndromes]

Recent Progress in Identifying Genetic and Epigenetic Contributions to Epilepsy

Small molecules as therapeutic agents for inborn errors of metabolism